Search company, investor...

Executives

2

Abogen Management Team

2 Team Members

Abogen has 2 executives. Abogen's current Founder, Chief Executive Officer is Ying Bo.

Name

Work History

Title

Status

Ying Bo

Founder, Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Ying Bo

Subscribe to see more

Work History

Title

Founder, Chief Executive Officer

Subscribe to see more

Status

Current

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Abogen to Competitors

N
NeoCura

NeoCura is committed to building a Ribonucleic acid (RNA) drug platform. It has built a multi-omics big data collection platform and multi-bionics database to perform in-depth drug target mining and fully automated drug design based on Artificial intelligence (AI) algorithms and core bioinformatic technologies. Through application in clinical innovative RNA drug development and next-generation and safe clinical precision diagnosis and treatment, it provides patients with one-stop full-cycle solutions from screening, diagnosis, and treatment to efficacy monitoring. It was founded in 2017 and is based in Beijing, China.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.